On June 1, Adimmune acquired influenza A virus subtype H1N1 vaccine isolated by CSL, and then officially launched its vaccine production program on August 6.
國光在 6 月 1 日取得澳洲 CSL 公司分離出的 A (H1N1) 疫苗株之後，隨即在 8 月 6 日正式啟動疫苗生產計畫。